Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Trends in breast cancer mortality in Sweden before and after implementation of mammography screening.

Haukka J, Byrnes G, Boniol M, Autier P.

PLoS One. 2011;6(9):e22422. doi: 10.1371/journal.pone.0022422. Epub 2011 Sep 26.

2.

Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.

Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group.

J Med Screen. 2012;19 Suppl 1:33-41. Review.

PMID:
22972809
3.

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.

Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E; EUROSCREEN Working Group.

J Med Screen. 2012;19 Suppl 1:14-25. Review.

PMID:
22972807
4.

[Screening for breast cancer: worries about its effectiveness].

Autier P.

Rev Prat. 2013 Dec;63(10):1369-77. Review. French.

PMID:
24579331
5.

Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review.

Autier P, Boniol M, Smans M, Sullivan R, Boyle P.

J R Soc Med. 2015 Nov;108(11):440-50. doi: 10.1177/0141076815593403. Epub 2015 Jul 7. Review.

6.

Benefits and harms of mammography screening.

Løberg M, Lousdal ML, Bretthauer M, Kalager M.

Breast Cancer Res. 2015 May 1;17:63. doi: 10.1186/s13058-015-0525-z. Review.

7.

Mammographic screening: evidence from randomised controlled trials.

de Koning HJ.

Ann Oncol. 2003 Aug;14(8):1185-9. Review.

PMID:
12881373
8.

Mammography screening. Benefits, harms, and informed choice.

Jørgensen KJ.

Dan Med J. 2013 Apr;60(4):B4614. Review.

PMID:
23651722
10.

Why is breast-cancer mortality declining?

Jatoi I, Miller AB.

Lancet Oncol. 2003 Apr;4(4):251-4. Review.

PMID:
12681269
11.
12.

Position paper: breast cancer screening, diagnosis, and treatment in Denmark.

Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E.

Acta Oncol. 2014 Apr;53(4):433-44. doi: 10.3109/0284186X.2013.874573. Epub 2014 Feb 5. Review.

PMID:
24495043
13.

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Jørgensen KJ, Gøtzsche PC.

BMJ. 2009 Jul 9;339:b2587. doi: 10.1136/bmj.b2587. Review.

14.

[Mammography screening].

Zwahlen M, Egger M.

Ther Umsch. 2013 Apr;70(4):205-12; discussion 212-3. doi: 10.1024/0040-5930/a000391. Review. German.

PMID:
23535547
15.

Breast cancer screening: controversy of impact.

Berry DA.

Breast. 2013 Aug;22 Suppl 2:S73-6. doi: 10.1016/j.breast.2013.07.013. Review.

16.

Pitfalls in using case-control studies for the evaluation of the effectiveness of breast screening programmes.

Autier P, Boniol M.

Eur J Cancer Prev. 2013 Sep;22(5):391-7. doi: 10.1097/CEJ.0b013e32835ccca4. Review.

PMID:
23263568
17.

Breast cancer screening: the evolving evidence.

Smith RA, Duffy SW, Tabár L.

Oncology (Williston Park). 2012 May;26(5):471-5, 479-81, 485-6. Review.

18.

How reliable is the evidence for screening mammography?

Feig SA.

Recent Results Cancer Res. 2003;163:129-39; discussion 264-6. Review.

PMID:
12903849
19.

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ; National Evaluation Team for Breast Cancer Screening.

Lancet. 2003 Apr 26;361(9367):1411-7. Review.

PMID:
12727393
20.

[Screening mammography for early diagnosis of breast cancer: facts, controversies, and the implementation in Israel].

Allweis TM, Nissan A, Spira RM, Sklair-Levy M, Freund HR, Peretz T.

Harefuah. 2003 Apr;142(4):281-6, 317. Review. Hebrew.

PMID:
12754879

Supplemental Content

Support Center